DEA Archived Press Releases

Press Releases before January 20, 2025
294 Results - Showing 51 to 60
PRESS RELEASE

Dark Web Drug Vendor and Clandestine Lab Manufacturer Sentenced to Prison for Trafficking in Meth and Fentanyl

MIAMI – On May 17, an Orange County, California, resident, Tenzin Orgil, 24, was sentenced to 168 months in federal prison for participating in a drug trafficking enterprise that included the sale of methamphetamine and fentanyl on the dark web, as well as the manufacture of ecstasy (also known as...
PRESS RELEASE

DEA Phoenix & the AZ Attorney General “Huddles Up” with NFL Alumni and Rise Up Glendale to Spread Awareness about Fentanyl

(PHOENIX) – The U.S. Drug Enforcement Administration Phoenix Division and Arizona Attorney General Kris Mayes are Huddling Up with NFL Alumni Health and Rise Up Glendale this Friday, May 17th to raise awareness and bring the community together to save lives. This community outreach and educational opportunity aims to provide...
PRESS RELEASE

Miami DEA Stress Fentanyl Dangers During Community Stakeholder Meeting

MIAMI—Drug Enforcement Administration (DEA) Miami Field Division personnel recently hosted an Operation Engage South Florida meeting with community stakeholders at First Baptist Church in Fort Lauderdale, Fla., to stress the dangers of fentanyl—especially regarding children. Operation Engage South F lorida is an opportunity to keep fentanyl prevention, awareness, and education...
PRESS RELEASE

DEA Rocky Mountain Field Division Recognizes National Fentanyl Awareness Day

Today, May 7, 2024 is National Fentanyl Awareness Day. This annual observance is held to bring needed attention and awareness to the threats from fentanyl and fake pills – and the lives lost to poisonings and overdoses. Fentanyl is the most significant drug threat the United States has faced in...
PRESS RELEASE

Success For DEA Rocky Mountain Field Division Prescription Drug Take Back Day

Thanks to community members, community partners, volunteers and members of the Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) the 26th National Prescription Drug Take Back Day was again a success. This past Saturday, often in challenging weather, people brought in their unneeded, unwanted or expired prescription medications to dozens...
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Enters 15th Year of Removing Unneeded Medications from Communities

El Paso – Together with its law enforcement partners, the Drug Enforcement Administration will host its 26th National Prescription Drug Take Back Day on Saturday, April 27, from 10 a.m. to 2 p.m. This event aims to remove unneeded prescriptions from homes to help prevent medication misuse by offering anonymous...
PRESS RELEASE

DEA Rocky Mountain Field Division Encourages Prescription Take Back This Saturday

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...
PRESS RELEASE

Federal Jury Finds California Drug Supplier Guilty of Distribution in Relation to Fatal Fentanyl Overdose of Fairbanks Man

FAIRBANKS, Alaska – A federal jury convicted a California drug dealer late Friday for his connection to the fatal fentanyl overdose of a Fairbanks man. According to court documents and evidence presented at trial, Junior Gafatasi Tulali, 48, was the original source of fentanyl pills that were sold to a...
PRESS RELEASE

New Haven Pharmacy and Owner Agree to Pay $120,000 to Settle Controlled Substances Act Allegations

NEW HAVEN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Cornerstone Pharmacy, Inc. (doing business as “Whalley Drug”), and its owner, YONG KWON, have entered into...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...